Yan C, Gao M, Deng Z
Basic Medical College, Guangzhou University of TCM, Guangzhou 510407.
Zhongguo Zhong Xi Yi Jie He Za Zhi. 1998 Jun;18(6):336-8.
Exploring the relationship between the plasma substance P(SP) and essential hypertension with left ventricular hypertrophy (EH-LVH) and the effect of promoting blood circulation and eliminating phlegm.
Before and after treatment, the changes of SP in patients wiith EH-LVH were measured by radioimmunoassay. Meanwhile, the changes of plasma renin activity (PRA), angiotension II (Ang II), left ventricular mass index (LVMI) and mean arterial pressure (MAP) were measured.
The level of plasma SP in patients with EH-LVH was markedly lower than that of patients without EH-NLVH and healthy subjects (P < 0.001); the levels of PRA and Ang II were higher than those in control group (P < 0.01 or < 0.05). After treatment, the level of SP was significantly increased, while LVMI, MAP, PRA and Ang II were significantly decrease (P < 0.01 or < 0.05). The levels between SP and LVMI, MAP, PRA, Ang II were markedly negative correlated (P < 0.01) while levels between LVMI and PRA, Ang II were markedly positive correlated.
The SP may be involved in the pathogenesis of EH-LVH; the mechanism of promoting blood circulation and eliminating phlegm reversing LVH might be related to its increasing the plasma SP.
探讨血浆P物质(SP)与原发性高血压伴左心室肥厚(EH-LVH)的关系以及活血化瘀祛痰法的作用。
采用放射免疫法检测EH-LVH患者治疗前后血浆SP的变化。同时,检测血浆肾素活性(PRA)、血管紧张素Ⅱ(AngⅡ)、左心室质量指数(LVMI)和平均动脉压(MAP)的变化。
EH-LVH患者血浆SP水平明显低于非EH-NLVH患者和健康受试者(P<0.001);PRA和AngⅡ水平高于对照组(P<0.01或<0.05)。治疗后,SP水平显著升高,而LVMI、MAP、PRA和AngⅡ显著降低(P<0.01或<0.05)。SP与LVMI、MAP、PRA、AngⅡ水平呈显著负相关(P<0.01),而LVMI与PRA、AngⅡ水平呈显著正相关。
SP可能参与EH-LVH的发病机制;活血化瘀祛痰法逆转LVH的机制可能与其升高血浆SP有关。